Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Serologic Follow-up of Middle East Respiratory Syndrome Coronavirus Cases and Contacts-Abu Dhabi, United Arab Emirates.

Al Hosani FI, Kim L, Khudhair A, Pham H, Al Mulla M, Al Bandar Z, Pradeep K, Elkheir KA, Weber S, Khoury M, Donnelly G, Younis N, El Saleh F, Abdalla M, Imambaccus H, Haynes LM, Thornburg NJ, Harcourt JL, Miao C, Tamin A, Hall AJ, Russell ES, Harris AM, Kiebler C, Mir RA, Pringle K, Alami NN, Abedi GR, Gerber SI.

Clin Infect Dis. 2019 Jan 18;68(3):409-418. doi: 10.1093/cid/ciy503.

PMID:
29905769
2.

The prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) antibodies in dromedary camels in Israel.

Harcourt JL, Rudoler N, Tamin A, Leshem E, Rasis M, Giladi M, Haynes LM.

Zoonoses Public Health. 2018 Sep;65(6):749-754. doi: 10.1111/zph.12482. Epub 2018 May 31.

3.

Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model.

Caidi H, Miao C, Thornburg NJ, Tripp RA, Anderson LJ, Haynes LM.

Antiviral Res. 2018 Jun;154:149-157. doi: 10.1016/j.antiviral.2018.04.014. Epub 2018 Apr 17.

PMID:
29678551
4.

Hemodilution and Endothelial Cell Regulation of Whole Blood Coagulation.

Orfeo T, Gissel M, Haynes LM, Pusateri A, Mann KG, Brummel-Ziedins KE.

Mil Med. 2018 Mar 1;183(suppl_1):175-182. doi: 10.1093/milmed/usx180.

PMID:
29635586
5.

Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape.

Wang L, Shi W, Chappell JD, Joyce MG, Zhang Y, Kanekiyo M, Becker MM, van Doremalen N, Fischer R, Wang N, Corbett KS, Choe M, Mason RD, Van Galen JG, Zhou T, Saunders KO, Tatti KM, Haynes LM, Kwong PD, Modjarrad K, Kong WP, McLellan JS, Denison MR, Munster VJ, Mascola JR, Graham BS.

J Virol. 2018 Apr 27;92(10). pii: e02002-17. doi: 10.1128/JVI.02002-17. Print 2018 May 15.

6.

Assessment of National Public Health and Reference Laboratory, Accra, Ghana, within Framework of Global Health Security.

Ogee-Nwankwo A, Opare D, Boateng G, Nyaku M, Haynes LM, Balajee SA, Conklin L, Icenogle JP, Rota PA, Waku-Kouomou D.

Emerg Infect Dis. 2017 Dec;23(13). doi: 10.3201/eid2313.170372.

7.

The Central Conserved Region (CCR) of Respiratory Syncytial Virus (RSV) G Protein Modulates Host miRNA Expression and Alters the Cellular Response to Infection.

Bakre AA, Harcourt JL, Haynes LM, Anderson LJ, Tripp RA.

Vaccines (Basel). 2017 Jul 3;5(3). pii: E16. doi: 10.3390/vaccines5030016.

8.

Probing the Dynamics of Clot-Bound Thrombin at Venous Shear Rates.

Haynes LM, Orfeo T, Mann KG, Everse SJ, Brummel-Ziedins KE.

Biophys J. 2017 Apr 25;112(8):1634-1644. doi: 10.1016/j.bpj.2017.03.002.

9.

Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective.

Boyoglu-Barnum S, Todd SO, Meng J, Barnum TR, Chirkova T, Haynes LM, Jadhao SJ, Tripp RA, Oomens AG, Moore ML, Anderson LJ.

J Virol. 2017 Apr 28;91(10). pii: e02059-16. doi: 10.1128/JVI.02059-16. Print 2017 May 15.

10.

RSV Growth and Quantification by Microtitration and qRT-PCR Assays.

Caidi H, Harcourt JL, Haynes LM.

Methods Mol Biol. 2016;1442:13-32. doi: 10.1007/978-1-4939-3687-8_2.

PMID:
27464684
11.

Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus.

Payne DC, Iblan I, Rha B, Alqasrawi S, Haddadin A, Al Nsour M, Alsanouri T, Ali SS, Harcourt J, Miao C, Tamin A, Gerber SI, Haynes LM, Al Abdallat MM.

Emerg Infect Dis. 2016 Oct;22(10):1824-6. doi: 10.3201/eid2210.160706. Epub 2016 Oct 15.

12.

Response to Emergence of Middle East Respiratory Syndrome Coronavirus, Abu Dhabi, United Arab Emirates, 2013-2014.

Al Hosani FI, Pringle K, Al Mulla M, Kim L, Pham H, Alami NN, Khudhair A, Hall AJ, Aden B, El Saleh F, Al Dhaheri W, Al Bandar Z, Bunga S, Abou Elkheir K, Tao Y, Hunter JC, Nguyen D, Turner A, Pradeep K, Sasse J, Weber S, Tong S, Whitaker BL, Haynes LM, Curns A, Gerber SI.

Emerg Infect Dis. 2016 Jul;22(7):1162-8. doi: 10.3201/eid2207.160040.

13.

Middle East Respiratory Syndrome Coronavirus Transmission in Extended Family, Saudi Arabia, 2014.

Arwady MA, Alraddadi B, Basler C, Azhar EI, Abuelzein E, Sindy AI, Sadiq BM, Althaqafi AO, Shabouni O, Banjar A, Haynes LM, Gerber SI, Feikin DR, Madani TA.

Emerg Infect Dis. 2016 Aug;22(8):1395-402. doi: 10.3201/eid2208.152015. Epub 2016 Aug 15.

14.

Transmission of Middle East Respiratory Syndrome Coronavirus Infections in Healthcare Settings, Abu Dhabi.

Hunter JC, Nguyen D, Aden B, Al Bandar Z, Al Dhaheri W, Abu Elkheir K, Khudair A, Al Mulla M, El Saleh F, Imambaccus H, Al Kaabi N, Sheikh FA, Sasse J, Turner A, Abdel Wareth L, Weber S, Al Ameri A, Abu Amer W, Alami NN, Bunga S, Haynes LM, Hall AJ, Kallen AJ, Kuhar D, Pham H, Pringle K, Tong S, Whitaker BL, Gerber SI, Al Hosani FI.

Emerg Infect Dis. 2016 Apr;22(4):647-56. doi: 10.3201/eid2204.151615.

15.

Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014.

Ng DL, Al Hosani F, Keating MK, Gerber SI, Jones TL, Metcalfe MG, Tong S, Tao Y, Alami NN, Haynes LM, Mutei MA, Abdel-Wareth L, Uyeki TM, Swerdlow DL, Barakat M, Zaki SR.

Am J Pathol. 2016 Mar;186(3):652-8. doi: 10.1016/j.ajpath.2015.10.024. Epub 2016 Feb 5.

PMID:
26857507
16.

Human cathelicidin, LL-37, inhibits respiratory syncytial virus infection in polarized airway epithelial cells.

Harcourt JL, McDonald M, Svoboda P, Pohl J, Tatti K, Haynes LM.

BMC Res Notes. 2016 Jan 5;9:11. doi: 10.1186/s13104-015-1836-y.

17.

Lack of Transmission among Close Contacts of Patient with Case of Middle East Respiratory Syndrome Imported into the United States, 2014.

Breakwell L, Pringle K, Chea N, Allen D, Allen S, Richards S, Pantones P, Sandoval M, Liu L, Vernon M, Conover C, Chugh R, DeMaria A, Burns R, Smole S, Gerber SI, Cohen NJ, Kuhar D, Haynes LM, Schneider E, Kumar A, Kapoor M, Madrigal M, Swerdlow DL, Feikin DR.

Emerg Infect Dis. 2015 Jul;21(7):1128-34. doi: 10.3201/eid2107.150054.

18.

An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice.

Boyoglu-Barnum S, Todd SO, Chirkova T, Barnum TR, Gaston KA, Haynes LM, Tripp RA, Moore ML, Anderson LJ.

Virology. 2015 Sep;483:117-25. doi: 10.1016/j.virol.2015.02.035. Epub 2015 May 15.

19.

Community-acquired pneumonia requiring hospitalization among U.S. children.

Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, Stockmann C, Anderson EJ, Grijalva CG, Self WH, Zhu Y, Patel A, Hymas W, Chappell JD, Kaufman RA, Kan JH, Dansie D, Lenny N, Hillyard DR, Haynes LM, Levine M, Lindstrom S, Winchell JM, Katz JM, Erdman D, Schneider E, Hicks LA, Wunderink RG, Edwards KM, Pavia AT, McCullers JA, Finelli L; CDC EPIC Study Team.

N Engl J Med. 2015 Feb 26;372(9):835-45. doi: 10.1056/NEJMoa1405870.

20.

Human Respiratory Coronaviruses Detected In Patients with Influenza-Like Illness in Arkansas, USA.

Silva CS, Mullis LB, Pereira O Jr, Saif LJ, Vlasova A, Zhang X, Owens RJ, Paulson D, Taylor D, Haynes LM, Azevedo MP.

Virol Mycol. 2014 Dec;2014(Suppl 2). pii: 004. Epub 2014 Mar 26.

21.

Health care worker contact with MERS patient, Saudi Arabia.

Hall AJ, Tokars JI, Badreddine SA, Saad ZB, Furukawa E, Al Masri M, Haynes LM, Gerber SI, Kuhar DT, Miao C, Trivedi SU, Pallansch MA, Hajjeh R, Memish ZA.

Emerg Infect Dis. 2014 Dec;20(12):2148-51. doi: 10.3201/eid2012.141211.

22.

Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice.

Boyoglu-Barnum S, Chirkova T, Todd SO, Barnum TR, Gaston KA, Jorquera P, Haynes LM, Tripp RA, Moore ML, Anderson LJ.

J Virol. 2014 Sep;88(18):10569-83. doi: 10.1128/JVI.01503-14. Epub 2014 Jul 2.

23.

Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description.

Al-Abdallat MM, Payne DC, Alqasrawi S, Rha B, Tohme RA, Abedi GR, Al Nsour M, Iblan I, Jarour N, Farag NH, Haddadin A, Al-Sanouri T, Tamin A, Harcourt JL, Kuhar DT, Swerdlow DL, Erdman DD, Pallansch MA, Haynes LM, Gerber SI; Jordan MERS-CoV Investigation Team.

Clin Infect Dis. 2014 Nov 1;59(9):1225-33. doi: 10.1093/cid/ciu359. Epub 2014 May 14.

24.

First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities - May 2014.

Bialek SR, Allen D, Alvarado-Ramy F, Arthur R, Balajee A, Bell D, Best S, Blackmore C, Breakwell L, Cannons A, Brown C, Cetron M, Chea N, Chommanard C, Cohen N, Conover C, Crespo A, Creviston J, Curns AT, Dahl R, Dearth S, DeMaria A, Echols F, Erdman DD, Feikin D, Frias M, Gerber SI, Gulati R, Hale C, Haynes LM, Heberlein-Larson L, Holton K, Ijaz K, Kapoor M, Kohl K, Kuhar DT, Kumar AM, Kundich M, Lippold S, Liu L, Lovchik JC, Madoff L, Martell S, Matthews S, Moore J, Murray LR, Onofrey S, Pallansch MA, Pesik N, Pham H, Pillai S, Pontones P, Pringle K, Pritchard S, Rasmussen S, Richards S, Sandoval M, Schneider E, Schuchat A, Sheedy K, Sherin K, Swerdlow DL, Tappero JW, Vernon MO, Watkins S, Watson J; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 May 16;63(19):431-6. Erratum in: MMWR Morb Mortal Wkly Rep. 2014 Jun 27;63(25):554.

25.

Stillbirth during infection with Middle East respiratory syndrome coronavirus.

Payne DC, Iblan I, Alqasrawi S, Al Nsour M, Rha B, Tohme RA, Abedi GR, Farag NH, Haddadin A, Al Sanhouri T, Jarour N, Swerdlow DL, Jamieson DJ, Pallansch MA, Haynes LM, Gerber SI, Al Abdallat MM; Jordan MERS-CoV Investigation Team.

J Infect Dis. 2014 Jun 15;209(12):1870-2. doi: 10.1093/infdis/jiu068. Epub 2014 Jan 28.

26.

Decrease in formalin-inactivated respiratory syncytial virus (FI-RSV) enhanced disease with RSV G glycoprotein peptide immunization in BALB/c mice.

Rey GU, Miao C, Caidi H, Trivedi SU, Harcourt JL, Tripp RA, Anderson LJ, Haynes LM.

PLoS One. 2013 Dec 23;8(12):e83075. doi: 10.1371/journal.pone.0083075. eCollection 2013.

27.

Progress and challenges in RSV prophylaxis and vaccine development.

Haynes LM.

J Infect Dis. 2013 Dec 15;208 Suppl 3:S177-83. doi: 10.1093/infdis/jit512. No abstract available.

PMID:
24265476
28.

Nanoparticle vaccines encompassing the respiratory syncytial virus (RSV) G protein CX3C chemokine motif induce robust immunity protecting from challenge and disease.

Jorquera PA, Choi Y, Oakley KE, Powell TJ, Boyd JG, Palath N, Haynes LM, Anderson LJ, Tripp RA.

PLoS One. 2013 Sep 10;8(9):e74905. doi: 10.1371/journal.pone.0074905. eCollection 2013.

29.

A respiratory syncytial virus (RSV) anti-G protein F(ab')2 monoclonal antibody suppresses mucous production and breathing effort in RSV rA2-line19F-infected BALB/c mice.

Boyoglu-Barnum S, Gaston KA, Todd SO, Boyoglu C, Chirkova T, Barnum TR, Jorquera P, Haynes LM, Tripp RA, Moore ML, Anderson LJ.

J Virol. 2013 Oct;87(20):10955-67. doi: 10.1128/JVI.01164-13. Epub 2013 Jul 24.

31.

Combination therapy using monoclonal antibodies against respiratory syncytial virus (RSV) G glycoprotein protects from RSV disease in BALB/c mice.

Caidi H, Harcourt JL, Tripp RA, Anderson LJ, Haynes LM.

PLoS One. 2012;7(12):e51485. doi: 10.1371/journal.pone.0051485. Epub 2012 Dec 27.

32.

Rivaroxaban delivery and reversal at a venous flow rate.

Haynes LM, Orfeo T, Mann KG.

Arterioscler Thromb Vasc Biol. 2012 Dec;32(12):2877-83. doi: 10.1161/ATVBAHA.112.300053. Epub 2012 Sep 27.

33.

Prothrombin activation by platelet-associated prothrombinase proceeds through the prethrombin-2 pathway via a concerted mechanism.

Haynes LM, Bouchard BA, Tracy PB, Mann KG.

J Biol Chem. 2012 Nov 9;287(46):38647-55. doi: 10.1074/jbc.M112.407791. Epub 2012 Sep 18.

34.

Effect of chemokine receptor CX3CR1 deficiency in a murine model of respiratory syncytial virus infection.

Johnson CH, Miao C, Blanchard EG, Caidi H, Radu GU, Harcourt JL, Haynes LM.

Comp Med. 2012 Feb;62(1):14-20.

35.

Membrane binding events in the initiation and propagation phases of tissue factor-initiated zymogen activation under flow.

Haynes LM, Dubief YC, Mann KG.

J Biol Chem. 2012 Feb 17;287(8):5225-34. doi: 10.1074/jbc.M111.302075. Epub 2011 Dec 20.

36.

Development of a recombinant truncated nucleocapsid protein based immunoassay for detection of antibodies against human coronavirus OC43.

Blanchard EG, Miao C, Haupt TE, Anderson LJ, Haynes LM.

J Virol Methods. 2011 Oct;177(1):100-6. doi: 10.1016/j.jviromet.2011.07.005. Epub 2011 Jul 27.

PMID:
21801752
37.

Evaluation of the Calu-3 cell line as a model of in vitro respiratory syncytial virus infection.

Harcourt JL, Caidi H, Anderson LJ, Haynes LM.

J Virol Methods. 2011 Jun;174(1-2):144-9. doi: 10.1016/j.jviromet.2011.03.027. Epub 2011 Mar 31.

PMID:
21458491
38.

Dilutional control of prothrombin activation at physiologically relevant shear rates.

Haynes LM, Dubief YC, Orfeo T, Mann KG.

Biophys J. 2011 Feb 2;100(3):765-773. doi: 10.1016/j.bpj.2010.12.3720.

39.

Prothrombin activation on the activated platelet surface optimizes expression of procoagulant activity.

Wood JP, Silveira JR, Maille NM, Haynes LM, Tracy PB.

Blood. 2011 Feb 3;117(5):1710-8. doi: 10.1182/blood-2010-09-311035. Epub 2010 Dec 3.

40.

Therapeutic targeting of respiratory syncytial virus G-protein.

Kauvar LM, Harcourt JL, Haynes LM, Tripp RA.

Immunotherapy. 2010 Sep;2(5):655-61. doi: 10.2217/imt.10.53. Review.

41.
42.

Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice.

Zhang W, Choi Y, Haynes LM, Harcourt JL, Anderson LJ, Jones LP, Tripp RA.

J Virol. 2010 Jan;84(2):1148-57. doi: 10.1128/JVI.01755-09. Epub 2009 Oct 28.

43.

Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice.

Haynes LM, Caidi H, Radu GU, Miao C, Harcourt JL, Tripp RA, Anderson LJ.

J Infect Dis. 2009 Aug 1;200(3):439-47. doi: 10.1086/600108.

PMID:
19545210
44.

Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab')2 components mediates reduced pulmonary inflammation in mice.

Miao C, Radu GU, Caidi H, Tripp RA, Anderson LJ, Haynes LM.

J Gen Virol. 2009 May;90(Pt 5):1119-23. doi: 10.1099/vir.0.009308-0. Epub 2009 Mar 4.

45.

Respiratory syncytial virus activates innate immunity through Toll-like receptor 2.

Murawski MR, Bowen GN, Cerny AM, Anderson LJ, Haynes LM, Tripp RA, Kurt-Jones EA, Finberg RW.

J Virol. 2009 Feb;83(3):1492-500. doi: 10.1128/JVI.00671-08. Epub 2008 Nov 19.

46.

Coronavirus antibodies in bat biologists.

Stockman LJ, Haynes LM, Miao C, Harcourt JL, Rupprecht CE, Ksiazek TG, Hyde TB, Fry AM, Anderson LJ.

Emerg Infect Dis. 2008 Jun;14(6):999-1000. doi: 10.3201/eid1406.070964. No abstract available.

47.
48.

Recombinant protein-based assays for detection of antibodies to severe acute respiratory syndrome coronavirus spike and nucleocapsid proteins.

Haynes LM, Miao C, Harcourt JL, Montgomery JM, Le MQ, Dryga SA, Kamrud KI, Rivers B, Babcock GJ, Oliver JB, Comer JA, Reynolds M, Uyeki TM, Bausch D, Ksiazek T, Thomas W, Alterson H, Smith J, Ambrosino DM, Anderson LJ.

Clin Vaccine Immunol. 2007 Mar;14(3):331-3. Epub 2007 Jan 17.

49.

Effects of torsion on O-H stretch overtone spectra and direct overtone photolysis of methyl hydroperoxide.

Haynes LM, Vogelhuber KM, Pippen JL, Hsieh S.

J Chem Phys. 2005 Dec 15;123(23):234306. Erratum in: J Chem Phys. 2007 May 28;126(20):209901.

PMID:
16392919
50.

Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins.

Tripp RA, Haynes LM, Moore D, Anderson B, Tamin A, Harcourt BH, Jones LP, Yilla M, Babcock GJ, Greenough T, Ambrosino DM, Alvarez R, Callaway J, Cavitt S, Kamrud K, Alterson H, Smith J, Harcourt JL, Miao C, Razdan R, Comer JA, Rollin PE, Ksiazek TG, Sanchez A, Rota PA, Bellini WJ, Anderson LJ.

J Virol Methods. 2005 Sep;128(1-2):21-8.

PMID:
15885812

Supplemental Content

Loading ...
Support Center